Use of Noncontrast Computed Tomography and Computed Tomographic Perfusion in Predicting Intracerebral Hemorrhage After Intravenous Alteplase Therapy
BACKGROUND AND PURPOSE—Intracerebral hemorrhage is a feared complication of intravenous alteplase therapy in patients with acute ischemic stroke. We explore the use of multimodal computed tomography in predicting this complication. METHODS—All patients were administered intravenous alteplase with/wi...
Saved in:
Published in | Stroke (1970) Vol. 48; no. 6; pp. 1548 - 1553 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Heart Association, Inc
01.06.2017
|
Subjects | |
Online Access | Get full text |
ISSN | 0039-2499 1524-4628 1524-4628 |
DOI | 10.1161/STROKEAHA.117.016616 |
Cover
Abstract | BACKGROUND AND PURPOSE—Intracerebral hemorrhage is a feared complication of intravenous alteplase therapy in patients with acute ischemic stroke. We explore the use of multimodal computed tomography in predicting this complication.
METHODS—All patients were administered intravenous alteplase with/without intra-arterial therapy. An age- and sex-matched case–control design with classic and conditional logistic regression techniques was chosen for analyses. Outcome was parenchymal hemorrhage on 24- to 48-hour imaging. Exposure variables were imaging (noncontrast computed tomography hypoattenuation degree, relative volume of very low cerebral blood volume, relative volume of cerebral blood flow ≤7 mL/min ·per 100 g, relative volume of Tmax ≥16 s with all volumes standardized to z axis coverage, mean permeability surface area product values within Tmax ≥8 s volume, and mean permeability surface area product values within ipsilesional hemisphere) and clinical variables (NIHSS [National Institutes of Health Stroke Scale], onset to imaging time, baseline systolic blood pressure, blood glucose, serum creatinine, treatment type, and reperfusion status).
RESULTS—One-hundred eighteen subjects (22 patients with parenchymal hemorrhage versus 96 without, median baseline NIHSS score of 15) were included in the final analysis. In multivariable regression, noncontrast computed tomography hypoattenuation grade (P<0.006) and computerized tomography perfusion white matter relative volume of very low cerebral blood volume (P=0.04) were the only significant variables associated with parenchymal hemorrhage on follow-up imaging (area under the curve, 0.73; 95% confidence interval, 0.63–0.83). Interrater reliability for noncontrast computed tomography hypoattenuation grade was moderate (κ=0.6).
CONCLUSIONS—Baseline hypoattenuation on noncontrast computed tomography and very low cerebral blood volume on computerized tomography perfusion are associated with development of parenchymal hemorrhage in patients with acute ischemic stroke receiving intravenous alteplase. |
---|---|
AbstractList | Intracerebral hemorrhage is a feared complication of intravenous alteplase therapy in patients with acute ischemic stroke. We explore the use of multimodal computed tomography in predicting this complication.BACKGROUND AND PURPOSEIntracerebral hemorrhage is a feared complication of intravenous alteplase therapy in patients with acute ischemic stroke. We explore the use of multimodal computed tomography in predicting this complication.All patients were administered intravenous alteplase with/without intra-arterial therapy. An age- and sex-matched case-control design with classic and conditional logistic regression techniques was chosen for analyses. Outcome was parenchymal hemorrhage on 24- to 48-hour imaging. Exposure variables were imaging (noncontrast computed tomography hypoattenuation degree, relative volume of very low cerebral blood volume, relative volume of cerebral blood flow ≤7 mL/min·per 100 g, relative volume of Tmax ≥16 s with all volumes standardized to z axis coverage, mean permeability surface area product values within Tmax ≥8 s volume, and mean permeability surface area product values within ipsilesional hemisphere) and clinical variables (NIHSS [National Institutes of Health Stroke Scale], onset to imaging time, baseline systolic blood pressure, blood glucose, serum creatinine, treatment type, and reperfusion status).METHODSAll patients were administered intravenous alteplase with/without intra-arterial therapy. An age- and sex-matched case-control design with classic and conditional logistic regression techniques was chosen for analyses. Outcome was parenchymal hemorrhage on 24- to 48-hour imaging. Exposure variables were imaging (noncontrast computed tomography hypoattenuation degree, relative volume of very low cerebral blood volume, relative volume of cerebral blood flow ≤7 mL/min·per 100 g, relative volume of Tmax ≥16 s with all volumes standardized to z axis coverage, mean permeability surface area product values within Tmax ≥8 s volume, and mean permeability surface area product values within ipsilesional hemisphere) and clinical variables (NIHSS [National Institutes of Health Stroke Scale], onset to imaging time, baseline systolic blood pressure, blood glucose, serum creatinine, treatment type, and reperfusion status).One-hundred eighteen subjects (22 patients with parenchymal hemorrhage versus 96 without, median baseline NIHSS score of 15) were included in the final analysis. In multivariable regression, noncontrast computed tomography hypoattenuation grade (P<0.006) and computerized tomography perfusion white matter relative volume of very low cerebral blood volume (P=0.04) were the only significant variables associated with parenchymal hemorrhage on follow-up imaging (area under the curve, 0.73; 95% confidence interval, 0.63-0.83). Interrater reliability for noncontrast computed tomography hypoattenuation grade was moderate (κ=0.6).RESULTSOne-hundred eighteen subjects (22 patients with parenchymal hemorrhage versus 96 without, median baseline NIHSS score of 15) were included in the final analysis. In multivariable regression, noncontrast computed tomography hypoattenuation grade (P<0.006) and computerized tomography perfusion white matter relative volume of very low cerebral blood volume (P=0.04) were the only significant variables associated with parenchymal hemorrhage on follow-up imaging (area under the curve, 0.73; 95% confidence interval, 0.63-0.83). Interrater reliability for noncontrast computed tomography hypoattenuation grade was moderate (κ=0.6).Baseline hypoattenuation on noncontrast computed tomography and very low cerebral blood volume on computerized tomography perfusion are associated with development of parenchymal hemorrhage in patients with acute ischemic stroke receiving intravenous alteplase.CONCLUSIONSBaseline hypoattenuation on noncontrast computed tomography and very low cerebral blood volume on computerized tomography perfusion are associated with development of parenchymal hemorrhage in patients with acute ischemic stroke receiving intravenous alteplase. Intracerebral hemorrhage is a feared complication of intravenous alteplase therapy in patients with acute ischemic stroke. We explore the use of multimodal computed tomography in predicting this complication. All patients were administered intravenous alteplase with/without intra-arterial therapy. An age- and sex-matched case-control design with classic and conditional logistic regression techniques was chosen for analyses. Outcome was parenchymal hemorrhage on 24- to 48-hour imaging. Exposure variables were imaging (noncontrast computed tomography hypoattenuation degree, relative volume of very low cerebral blood volume, relative volume of cerebral blood flow ≤7 mL/min·per 100 g, relative volume of T ≥16 s with all volumes standardized to axis coverage, mean permeability surface area product values within T ≥8 s volume, and mean permeability surface area product values within ipsilesional hemisphere) and clinical variables (NIHSS [National Institutes of Health Stroke Scale], onset to imaging time, baseline systolic blood pressure, blood glucose, serum creatinine, treatment type, and reperfusion status). One-hundred eighteen subjects (22 patients with parenchymal hemorrhage versus 96 without, median baseline NIHSS score of 15) were included in the final analysis. In multivariable regression, noncontrast computed tomography hypoattenuation grade ( <0.006) and computerized tomography perfusion white matter relative volume of very low cerebral blood volume ( =0.04) were the only significant variables associated with parenchymal hemorrhage on follow-up imaging (area under the curve, 0.73; 95% confidence interval, 0.63-0.83). Interrater reliability for noncontrast computed tomography hypoattenuation grade was moderate (κ=0.6). Baseline hypoattenuation on noncontrast computed tomography and very low cerebral blood volume on computerized tomography perfusion are associated with development of parenchymal hemorrhage in patients with acute ischemic stroke receiving intravenous alteplase. BACKGROUND AND PURPOSE—Intracerebral hemorrhage is a feared complication of intravenous alteplase therapy in patients with acute ischemic stroke. We explore the use of multimodal computed tomography in predicting this complication. METHODS—All patients were administered intravenous alteplase with/without intra-arterial therapy. An age- and sex-matched case–control design with classic and conditional logistic regression techniques was chosen for analyses. Outcome was parenchymal hemorrhage on 24- to 48-hour imaging. Exposure variables were imaging (noncontrast computed tomography hypoattenuation degree, relative volume of very low cerebral blood volume, relative volume of cerebral blood flow ≤7 mL/min ·per 100 g, relative volume of Tmax ≥16 s with all volumes standardized to z axis coverage, mean permeability surface area product values within Tmax ≥8 s volume, and mean permeability surface area product values within ipsilesional hemisphere) and clinical variables (NIHSS [National Institutes of Health Stroke Scale], onset to imaging time, baseline systolic blood pressure, blood glucose, serum creatinine, treatment type, and reperfusion status). RESULTS—One-hundred eighteen subjects (22 patients with parenchymal hemorrhage versus 96 without, median baseline NIHSS score of 15) were included in the final analysis. In multivariable regression, noncontrast computed tomography hypoattenuation grade (P<0.006) and computerized tomography perfusion white matter relative volume of very low cerebral blood volume (P=0.04) were the only significant variables associated with parenchymal hemorrhage on follow-up imaging (area under the curve, 0.73; 95% confidence interval, 0.63–0.83). Interrater reliability for noncontrast computed tomography hypoattenuation grade was moderate (κ=0.6). CONCLUSIONS—Baseline hypoattenuation on noncontrast computed tomography and very low cerebral blood volume on computerized tomography perfusion are associated with development of parenchymal hemorrhage in patients with acute ischemic stroke receiving intravenous alteplase. |
Author | McDougall, Connor d’Esterre, Christopher D. Fainardi, Enrico Shankar, Jai Jai Shiva Sajobi, Tolulope T. Menon, Bijoy K. Najm, Mohamed Demchuk, Andrew M. Boesen, Mari E. Hur, Lisa Goyal, Mayank Aviv, Richard I. Rubiera, Marta Lee, Ting-Yim Pordeli, Pooneh Khaw, Alexander V. Batchelor, Connor Al-Ajlan, Fahad S. Hill, Michael D. |
AuthorAffiliation | From the Calgary Stroke Program, Department of Clinical Neurosciences (P.P., C.D.d., M.N., F.S.A.-A., C.M., L.H., M.D.H., A.M.D., T.T.S., M.G., B.K.M.), Department of Radiology (C.D.d., M.D.H., A.M.D., M.G., T.-Y.L., B.K.M.), Department of Community Health Sciences (P.P., M.D.H., T.T.S., B.K.M.), and Biomedical Engineering Graduate Program (M.E.B.), University of Calgary, Alberta; Hotchkiss Brain Institute, Calgary, Alberta (P.P., M.D.H., A.M.D., T.T.S., M.G., B.K.M.); Seaman Family Research Centre, Foothills Medical Centre, Calgary, Alberta (C.B., C.D.d., M.N., M.E.B., L.H., M.D.H., A.M.D., M.G., B.K.M.); Department of Neuroradiology, Sunnybrook Health Sciences Centre, University of Toronto, Ontario (R.I.A.); Department of Diagnostic Imaging, University Hospital, Florence, Italy (E.F.); Department of Neurology, Hospital Vall d’Hebron, Ps. Vall d’Hebron, Barcelona, Spain (M.R.); Lawson Health Research Institute and Robarts Research Institute, London, Ontario (A.V.K., T.-Y.L.); Departme |
AuthorAffiliation_xml | – name: From the Calgary Stroke Program, Department of Clinical Neurosciences (P.P., C.D.d., M.N., F.S.A.-A., C.M., L.H., M.D.H., A.M.D., T.T.S., M.G., B.K.M.), Department of Radiology (C.D.d., M.D.H., A.M.D., M.G., T.-Y.L., B.K.M.), Department of Community Health Sciences (P.P., M.D.H., T.T.S., B.K.M.), and Biomedical Engineering Graduate Program (M.E.B.), University of Calgary, Alberta; Hotchkiss Brain Institute, Calgary, Alberta (P.P., M.D.H., A.M.D., T.T.S., M.G., B.K.M.); Seaman Family Research Centre, Foothills Medical Centre, Calgary, Alberta (C.B., C.D.d., M.N., M.E.B., L.H., M.D.H., A.M.D., M.G., B.K.M.); Department of Neuroradiology, Sunnybrook Health Sciences Centre, University of Toronto, Ontario (R.I.A.); Department of Diagnostic Imaging, University Hospital, Florence, Italy (E.F.); Department of Neurology, Hospital Vall d’Hebron, Ps. Vall d’Hebron, Barcelona, Spain (M.R.); Lawson Health Research Institute and Robarts Research Institute, London, Ontario (A.V.K., T.-Y.L.); Department of Clinical Neurosciences, University of Western Ontario (A.V.K.); Department of Neurosciences, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia (F.S.A.-A.); and Department of Neurology, Neuroradiology, Dalhousie University, Halifax, Nova Scotia (J.J.S.S.) |
Author_xml | – sequence: 1 givenname: Connor surname: Batchelor fullname: Batchelor, Connor organization: From the Calgary Stroke Program, Department of Clinical Neurosciences (P.P., C.D.d., M.N., F.S.A.-A., C.M., L.H., M.D.H., A.M.D., T.T.S., M.G., B.K.M.), Department of Radiology (C.D.d., M.D.H., A.M.D., M.G., T.-Y.L., B.K.M.), Department of Community Health Sciences (P.P., M.D.H., T.T.S., B.K.M.), and Biomedical Engineering Graduate Program (M.E.B.), University of Calgary, Alberta; Hotchkiss Brain Institute, Calgary, Alberta (P.P., M.D.H., A.M.D., T.T.S., M.G., B.K.M.); Seaman Family Research Centre, Foothills Medical Centre, Calgary, Alberta (C.B., C.D.d., M.N., M.E.B., L.H., M.D.H., A.M.D., M.G., B.K.M.); Department of Neuroradiology, Sunnybrook Health Sciences Centre, University of Toronto, Ontario (R.I.A.); Department of Diagnostic Imaging, University Hospital, Florence, Italy (E.F.); Department of Neurology, Hospital Vall d’Hebron, Ps. Vall d’Hebron, Barcelona, Spain (M.R.); Lawson Health Research Institute and Robarts Research Institute, London, Ontario (A.V.K., T.-Y.L.); Department of Clinical Neurosciences, University of Western Ontario (A.V.K.); Department of Neurosciences, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia (F.S.A.-A.); and Department of Neurology, Neuroradiology, Dalhousie University, Halifax, Nova Scotia (J.J.S.S.) – sequence: 2 givenname: Pooneh surname: Pordeli fullname: Pordeli, Pooneh – sequence: 3 givenname: Christopher surname: d’Esterre middlename: D. fullname: d’Esterre, Christopher D. – sequence: 4 givenname: Mohamed surname: Najm fullname: Najm, Mohamed – sequence: 5 givenname: Fahad surname: Al-Ajlan middlename: S. fullname: Al-Ajlan, Fahad S. – sequence: 6 givenname: Mari surname: Boesen middlename: E. fullname: Boesen, Mari E. – sequence: 7 givenname: Connor surname: McDougall fullname: McDougall, Connor – sequence: 8 givenname: Lisa surname: Hur fullname: Hur, Lisa – sequence: 9 givenname: Enrico surname: Fainardi fullname: Fainardi, Enrico – sequence: 10 givenname: Jai Jai surname: Shankar middlename: Shiva fullname: Shankar, Jai Jai Shiva – sequence: 11 givenname: Marta surname: Rubiera fullname: Rubiera, Marta – sequence: 12 givenname: Alexander surname: Khaw middlename: V. fullname: Khaw, Alexander V. – sequence: 13 givenname: Michael surname: Hill middlename: D. fullname: Hill, Michael D. – sequence: 14 givenname: Andrew surname: Demchuk middlename: M. fullname: Demchuk, Andrew M. – sequence: 15 givenname: Tolulope surname: Sajobi middlename: T. fullname: Sajobi, Tolulope T. – sequence: 16 givenname: Mayank surname: Goyal fullname: Goyal, Mayank – sequence: 17 givenname: Ting-Yim surname: Lee fullname: Lee, Ting-Yim – sequence: 18 givenname: Richard surname: Aviv middlename: I. fullname: Aviv, Richard I. – sequence: 19 givenname: Bijoy surname: Menon middlename: K. fullname: Menon, Bijoy K. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28446625$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkcFu1DAQhi1URLeFN0DIRy4pduw4CbdoVbpVK1rB9hw5zmRjSOxgO1T7Hn3guqT0gFA7l9HY__drNP8ROjDWAELvKTmhVNBP37ffri5Oq00Vx_yEUCGoeIVWNEt5wkVaHKAVIaxMUl6Wh-jI-x-EkJQV2Rt0mBacC5FmK3R34wHbDn-1RlkTnPQBr-04zQFavLWj3Tk59XssTfufd63wNbhu9toarA2-dtBqFbTZ4fMHMwUOGicHvIHROtfLHeCqC-CW799g7OxxNQSYBhkX2fYQbfdv0etODh7ePfZjdPPldLveJJdXZ-fr6jJRLBMiKQljigresUYoWpCCdzlICqAayVlHVd5C1nDW8iZWUWSipKzLKJCybFOi2DH6uPhOzv6awYd61F7BMEgDcbGaFmWap4xmJEo_PErnZoS2npwepdvXfy8ZBXwRKGe9d9A9SSipHwKrnwKLY14vgUXs8z-Y0kEG_ScLPbwEFwt8a-MJnf85zLfg6h7kEPrn0XsCnLE0 |
CitedBy_id | crossref_primary_10_1002_ana_25466 crossref_primary_10_1177_02841851211035892 crossref_primary_10_1016_j_yacr_2020_05_003 crossref_primary_10_1155_2021_9933015 crossref_primary_10_1111_ene_14985 crossref_primary_10_1177_08465371211018369 crossref_primary_10_1212_CON_0000000000000839 crossref_primary_10_1212_WNL_0000000000209939 crossref_primary_10_1161_STROKEAHA_122_041241 crossref_primary_10_17116_jnevro202412412234 crossref_primary_10_1016_j_nic_2018_06_007 crossref_primary_10_1148_radiol_2019182041 crossref_primary_10_1161_STROKEAHA_123_040806 crossref_primary_10_1161_STROKEAHA_124_049013 crossref_primary_10_12677_ACM_2022_1281140 crossref_primary_10_1159_000537729 crossref_primary_10_3390_jcm10051086 crossref_primary_10_2214_AJR_21_25846 |
Cites_doi | 10.1161/STROKEAHA.107.510768 10.1148/radiol.2503080257 10.1111/j.1552-6569.2004.tb00214.x 10.1002/ana.23546 10.1038/jcbfm.2013.203 10.1002/ana.23837 10.1038/nature03987 10.1161/STROKEAHA.114.008171 10.1016/j.acra.2012.08.013 10.1056/NEJM199512143332401 10.1056/NEJMoa1414905 10.1159/000437114 10.1016/S0140-6736(98)08020-9 10.1161/STROKEAHA.109.562116 10.1161/STROKEAHA.114.005249 10.1161/STROKEAHA.109.554386 10.3389/fneur.2013.00069 10.1136/bmj.i969 10.1148/radiol.2432060137 10.1007/s00424-005-1461-z 10.1002/ana.20782 10.1161/STROKEAHA.113.002396 10.1212/01.wnl.0000330297.58334.dd 10.1161/STROKEAHA.106.480475 10.1161/STROKEAHA.115.009250 10.1161/01.str.0000016405.06729.83 10.1161/STROKEAHA.112.660415 |
ContentType | Journal Article |
Copyright | 2017 American Heart Association, Inc. |
Copyright_xml | – notice: 2017 American Heart Association, Inc. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1161/STROKEAHA.117.016616 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4628 |
EndPage | 1553 |
ExternalDocumentID | 28446625 10_1161_STROKEAHA_117_016616 10.1161/STROKEAHA.117.016616 |
Genre | Research Support, Non-U.S. Gov't Multicenter Study Journal Article |
GrantInformation_xml | – fundername: CIHR |
GroupedDBID | --- .XZ .Z2 01R 0R~ 123 1J1 2WC 40H 4Q1 4Q2 4Q3 53G 5RE 5VS 6PF 71W 77Y 7O~ AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AAUEB AAXQO AAYEP ABASU ABBUW ABDIG ABJNI ABPXF ABQRW ABVCZ ABXVJ ABXYN ABZAD ABZZY ACCJW ACDDN ACDOF ACEWG ACGFS ACGOD ACILI ACLDA ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADGGA ADHPY AE3 AE6 AEBDS AEETU AENEX AFBFQ AFDTB AFEXH AFMBP AFNMH AFSOK AFUWQ AGINI AHMBA AHOMT AHQNM AHQVU AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC AYCSE BAWUL BCGUY BOYCO BQLVK C45 CS3 DIK DIWNM DU5 E.X E3Z EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- GNXGY GQDEL GX1 H0~ H13 HLJTE HZ~ IKREB IKYAY IN~ IPNFZ J5H JF9 JG8 JK3 JK8 K8S KD2 KMI KQ8 L-C L7B N9A N~7 N~B O9- OAG OAH OB3 ODMTH OGROG OHYEH OK1 OL1 OLG OLH OLU OLV OLY OLZ OPUJH OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P2P PQQKQ RAH RIG RLZ S4R S4S TEORI TSPGW V2I VVN W3M W8F WH7 WOQ WOW X3V X3W XXN XYM YFH ZB8 .3C .55 .GJ 3O- A9M AAQQT AAYJJ AAYXX ADFPA ADGHP ADNKB AFFNX AHRYX AJNYG BS7 CITATION DUNZO FW0 M18 N4W N~M OCUKA ODA ORVUJ OUVQU P-K R58 T8P X7M YHZ YQJ YYP ZGI ZZMQN ACIJW CGR CUY CVF ECM EIF NPM YCJ 7X8 ADSXY |
ID | FETCH-LOGICAL-c3566-9033c164f3b6c18084f7ea1eecba43f1c7de5b43d4bbbb8856913f51e099d20c3 |
ISSN | 0039-2499 1524-4628 |
IngestDate | Thu Sep 04 23:44:06 EDT 2025 Thu Apr 03 07:03:12 EDT 2025 Thu Apr 24 22:58:01 EDT 2025 Tue Jul 01 03:31:50 EDT 2025 Fri May 16 03:42:52 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | blood glucose blood pressure creatinine stroke permeability |
Language | English |
License | 2017 American Heart Association, Inc. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c3566-9033c164f3b6c18084f7ea1eecba43f1c7de5b43d4bbbb8856913f51e099d20c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 28446625 |
PQID | 1892723150 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_1892723150 pubmed_primary_28446625 crossref_primary_10_1161_STROKEAHA_117_016616 crossref_citationtrail_10_1161_STROKEAHA_117_016616 wolterskluwer_health_10_1161_STROKEAHA_117_016616 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-06-01 |
PublicationDateYYYYMMDD | 2017-06-01 |
PublicationDate_xml | – month: 06 year: 2017 text: 2017-06-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Stroke (1970) |
PublicationTitleAlternate | Stroke |
PublicationYear | 2017 |
Publisher | American Heart Association, Inc |
Publisher_xml | – name: American Heart Association, Inc |
References | Lee TY (e_1_3_3_28_2) 2003; 47 e_1_3_3_17_2 e_1_3_3_16_2 e_1_3_3_19_2 e_1_3_3_18_2 e_1_3_3_13_2 e_1_3_3_12_2 e_1_3_3_15_2 e_1_3_3_14_2 e_1_3_3_11_2 e_1_3_3_10_2 e_1_3_3_6_2 e_1_3_3_5_2 e_1_3_3_8_2 e_1_3_3_7_2 e_1_3_3_9_2 e_1_3_3_27_2 e_1_3_3_29_2 e_1_3_3_24_2 e_1_3_3_23_2 e_1_3_3_26_2 e_1_3_3_25_2 e_1_3_3_2_2 e_1_3_3_20_2 e_1_3_3_4_2 e_1_3_3_22_2 e_1_3_3_3_2 e_1_3_3_21_2 |
References_xml | – ident: e_1_3_3_5_2 doi: 10.1161/STROKEAHA.107.510768 – ident: e_1_3_3_10_2 doi: 10.1148/radiol.2503080257 – volume: 47 start-page: 171 year: 2003 ident: e_1_3_3_28_2 article-title: CT imaging of angiogenesis. publication-title: Q J Nucl Med – ident: e_1_3_3_16_2 doi: 10.1111/j.1552-6569.2004.tb00214.x – ident: e_1_3_3_7_2 doi: 10.1002/ana.23546 – ident: e_1_3_3_25_2 doi: 10.1038/jcbfm.2013.203 – ident: e_1_3_3_9_2 doi: 10.1002/ana.23837 – ident: e_1_3_3_24_2 doi: 10.1038/nature03987 – ident: e_1_3_3_20_2 doi: 10.1161/STROKEAHA.114.008171 – ident: e_1_3_3_29_2 doi: 10.1016/j.acra.2012.08.013 – ident: e_1_3_3_2_2 doi: 10.1056/NEJM199512143332401 – ident: e_1_3_3_13_2 doi: 10.1056/NEJMoa1414905 – ident: e_1_3_3_11_2 doi: 10.1159/000437114 – ident: e_1_3_3_14_2 doi: 10.1016/S0140-6736(98)08020-9 – ident: e_1_3_3_19_2 doi: 10.1161/STROKEAHA.109.562116 – ident: e_1_3_3_21_2 doi: 10.1161/STROKEAHA.114.005249 – ident: e_1_3_3_6_2 doi: 10.1161/STROKEAHA.109.554386 – ident: e_1_3_3_15_2 doi: 10.3389/fneur.2013.00069 – ident: e_1_3_3_26_2 doi: 10.1136/bmj.i969 – ident: e_1_3_3_17_2 doi: 10.1148/radiol.2432060137 – ident: e_1_3_3_23_2 doi: 10.1007/s00424-005-1461-z – ident: e_1_3_3_18_2 doi: 10.1002/ana.20782 – ident: e_1_3_3_27_2 doi: 10.1161/STROKEAHA.113.002396 – ident: e_1_3_3_4_2 doi: 10.1212/01.wnl.0000330297.58334.dd – ident: e_1_3_3_8_2 doi: 10.1161/STROKEAHA.106.480475 – ident: e_1_3_3_12_2 doi: 10.1161/STROKEAHA.115.009250 – ident: e_1_3_3_22_2 doi: 10.1161/01.str.0000016405.06729.83 – ident: e_1_3_3_3_2 doi: 10.1161/STROKEAHA.112.660415 |
SSID | ssj0002385 |
Score | 2.3322372 |
Snippet | BACKGROUND AND PURPOSE—Intracerebral hemorrhage is a feared complication of intravenous alteplase therapy in patients with acute ischemic stroke. We explore... Intracerebral hemorrhage is a feared complication of intravenous alteplase therapy in patients with acute ischemic stroke. We explore the use of multimodal... |
SourceID | proquest pubmed crossref wolterskluwer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1548 |
SubjectTerms | Aged Aged, 80 and over Cerebral Hemorrhage - chemically induced Cerebral Hemorrhage - diagnostic imaging Cerebrovascular Circulation Female Fibrinolytic Agents - adverse effects Humans Male Middle Aged Prognosis Stroke - diagnostic imaging Stroke - drug therapy Tissue Plasminogen Activator - adverse effects Tomography, X-Ray Computed - methods |
Title | Use of Noncontrast Computed Tomography and Computed Tomographic Perfusion in Predicting Intracerebral Hemorrhage After Intravenous Alteplase Therapy |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28446625 https://www.proquest.com/docview/1892723150 |
Volume | 48 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtNAEF2FIiEQQtwK4aZF4q1y8Hq9vjwGCIpALYEmUt-s9XqtljZ25Tgg8R18H9_CjHfjODQqlDxYkZNMHM_J7lzOzBDyygOXS3CVOalQ3PEl-Ckx7PuOlgEY15kWLMWM7v5BMJ75H47EUa_3q8NaWtbpQP3YWlfyP1qFc6BXrJK9gmZboXACnoN-4QgahuM_6XhmAvEHZdEwzuWi3rNTGpAfM7fdqJv8wMXzyInXVb5cWLbjpMKcTW0YBCBM6QqTyth7eF5W1TGSe4bNRPHm5W-muevwrNbnYIFr5G60_QmstXtYV-VpY8SyOHQ7QYc3EsFiQwXNxOuWIzzBZqCmZntSloVuw9XZipcRj7C5g4mdd3oj7L0btJFt-dVEestjObfVWzaywcI1A2u1WnPM_pgBSgNtF2jPd7CetruC-1EHqd3lGP2xztaOM5K2bxsBbhuH0y-fPo6G4yFmsgdgCwdsS5fuP3bPltPYeFMBS1op2Ec9MVKuketeCLYdkgY-r7vZg7lkJmzY32lLO0HK623Xsmk6XfCHbpHb30ukWCxOmwqLjp00vUvuWAeHDg1a75GeLu6TG_uWwvGA_ATQ0jKnHdDSFTjpGrQUQLvl_ImiLWjpSUHXoKUboKVr0NIGtLQDWtqCllrQPiSz96Pp27FjR4M4ioMD4sQu5wo8_ZyngWKRG_l5qCXTWqXS5zlTISwzqc8zP4VHFIkgZjwXTINDlHmu4rtkpwAMPyY0zSMhZJxKHoGUSMQ5E4F0MzCNY5Vmsk_46q4nyvbNx_EtZ8llGu8Tp_3Uuekb85f3v1wpNIEFHrN2stBwSxIWxV4IXphw--SR0XQrEWxLPwg80SdsQ_WJKaK-9BufXPEKn5Kb6z_pM7JTV0v9HAzyOn3RoPo35R3fZw |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Use+of+Noncontrast+Computed+Tomography+and+Computed+Tomographic+Perfusion+in+Predicting+Intracerebral+Hemorrhage+After+Intravenous+Alteplase+Therapy&rft.jtitle=Stroke+%281970%29&rft.au=Batchelor%2C+Connor&rft.au=Pordeli%2C+Pooneh&rft.au=d%E2%80%99Esterre%2C+Christopher+D.&rft.au=Najm%2C+Mohamed&rft.date=2017-06-01&rft.issn=0039-2499&rft.eissn=1524-4628&rft.volume=48&rft.issue=6&rft.spage=1548&rft.epage=1553&rft_id=info:doi/10.1161%2FSTROKEAHA.117.016616&rft.externalDBID=n%2Fa&rft.externalDocID=10_1161_STROKEAHA_117_016616 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0039-2499&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0039-2499&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0039-2499&client=summon |